Computational Drug Discovery

Discriminating between active and inactive compounds using binding energy calculations – a case study

Xanthine oxidase inhibitors fall into two classes, those which co not (e.g. febuxostat). Recently we discovered a novel pyrimidine enzymatic assays. Molecular docking studies showed binding pattern similar to that of febuxostat. Shifting a nitrogen …